Eastman Chemical stock
EMNNYSEEastman Chemical Company, Basic MaterialsISIN US2774321002
60Score 60 out of 100, Neutral
Price and trend
62 / 100
Price history
+9.2% in one yearThe chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Below the 200-day line: the price is 6.2% below it.
Since September 2026 the 50-day line has been below the 200-day line; the trend has turned down.
Normal: the price is neither overheated nor sold off (RSI 54).
The price is 18% below its 52-week high. Largest decline in 20 years: 77% (May 2008 to March 2009).
Chart figures for advanced users
- SMA 50$65.80
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$70.89
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)54
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDabove the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$56.37
- The lowest closing price of the last twelve months.
- Resistance$81.36
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Eastman Chemical Company belongs to the Chemicals (Specialty) industry (United States) and, with a market value of $7.6B, is number 41 of 108 companies in its industry on MEQIRI.
- In fiscal 2025 it reported revenue of $8.75B (down 6.7% year on year) and earnings of $474M (down 47.6%).
- For fiscal 2026, analysts expect on average revenue of $9.24B (up 5.6%) and adjusted earnings per share of $6.13 (up 13.4%).
Show more
- MEQIRI Score 60 out of 100 (Neutral): rank 208 of 467 in Basic Materials, median 58.
- The P/E is 11.9 (Chemicals (Specialty) median 24.4, own median of recent years 12.7).
- Our model puts fair value at $132.18, with the price 50% below it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Reliable dividendNo dividend cut for over 32 years.Capital allocation 70
- Below fair valuePrice 50% below the fair value of $132.18.Valuation 88
- Share buybacksShare count down 15% since 2020.Capital allocation 70
Weaknesses
None of our weakness checks flags anything. Crash risk is measured separately.
Its standout strengths are valuation and fundamentals, while profitability and growth hold the score back.
Daily figure as of 12 Nov 2026
How the score is calculatedScore overview
Score since yesterday from 59 to 60.
Fundamentals are strong, with stable profits.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk medium
How well MEQIRI warnsIn the middle among smaller stocks.
From 2016 to 2025, 20 in 100 such stocks fell 30% or more within a year, against a group average of 23 in 100.
What drives the risk
- cyclical sector (energy or materials), as a group, crashed more often in the backtest
Valuation
Valuation signal
Significantly undervaluedIn our model the price counts as cheap below $101.68 and expensive above $188.83 (uncertainty medium, based on the price swings of the past year).
The two parts of the fair value come to $127.73 (cash-flow model) and $136.64 (industry comparison), and the gap between them shows how uncertain the estimate is. The price is below both.
Calculated with a cost of equity of 9.4%. At 10.4% the fair value would be $121.69, at 8.4% it would be $147.34.
Valuation metrics
Half from the cash-flow model, half from earnings times the industry P/E (24.4).
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the twelve months to 30 Sep 2026, revenue rose 0.3% on the twelve months before. Revenue has stayed largely stable since 2006.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2025: gross 21%, operating 11%, net 5%.
Debt & balance sheet
latest quarterModerate debt, and interest is adequately covered.
Earnings
- Next earnings
- 4 Feb 2027in 84 days
- Last reported
- 29 Oct 2026EPS reported $1.84 (expected $1.93)below expectations
Analyst estimates
Analysts have cut their 2026 earnings estimate by 3.4% since 15 Oct 2026. Falling estimates often precede bad news.
- Earnings per share
- $6.13−3.4%
- Revenue
- $9.24B−0.3%
- Earnings per share
- $6.52−3.0%
- Revenue
- $9.47B+0.2%
MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
Company outlook mixed
Share price after the results: +2.7%Revenue outlook brought a bit below the earlier range on capacity constraints and a slower market, while the full-year earnings view is better than in April.
“We've just brought the revenue outlook to be a bit below the range we gave you earlier.”The outlook is not part of the score and not a recommendation to buy or sell.
From the earnings call on 31 Jul 2026 (fiscal Q2 2026), read by AI.
Insiders
Open-market purchases and sales by executives, board members and major holders
One insider bought on the open market in the last 6 months, $159,989 in total. One insider sold, $234,111 in total.
Sales say less than purchases: many insiders sell on a fixed plan, for taxes or to diversify.
Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.
What happened at Eastman Chemical
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
467 rated companies in Basic Materials
- This company
- 60
- Sector median
- 58
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Chemicals (Specialty)
The next larger and next smaller companies by market value
- Element SolutionsESI $8.26B54
- WestlakeWLK $8.17B39
- SRFSRF.NS $7.94B59
- Axalta Coating SystemsAXTA $7.93B71
- China Rare Earth Resources and Technology000831.SZ $7.57B52
- Hengyi Petrochemical000703.SZ $7.14B54
- Huafon Chemical002064.SZ $6.92B60
- IMCDIMCD.AS $6.72B65
ETFs that hold Eastman Chemical
Held by 11 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| State Street SPDR S&P Global Dividend Aristocrats UCITS ETF (Dist)ZPRG | 1.18% | 0.45% | €1.63B |
| iShares Dow Jones U.S. Select Dividend UCITS ETF (DE)EXX5 | 0.68% | 0.31% | €415.03M |
| iShares S&P SmallCap 600 UCITS ETFIUS3 | 0.44% | 0.30% | €2.28B |
Show 5 more
| State Street SPDR MSCI USA Small Cap Value Weighted UCITS ETFZPRV | 0.22% | 0.30% | €944.34M |
| iShares MSCI World Small Cap UCITS ETFIUSN | 0.07% | 0.35% | €8.19B |
| Invesco RAFI US Fundamental Value UCITS ETF6PSA | 0.06% | 0.39% | €1.23B |
| State Street SPDR MSCI All Country World Investable Market UCITS ETF (Acc)SPYI | 0.04% | 0.17% | €8.6B |
| Invesco RAFI All-World Fundamental Value UCITS ETFPSWD | 0.03% | 0.39% | €446.84M |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 11 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 30 Jun 2023)
- Valuation signal Undervalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.